| Generic Name | Famotidine |
|---|---|
| Drug Class | H₂ Receptor Antagonist (H₂RA) |
| Indications |
|
| Mechanism of Action | Selective histamine H₂ receptor antagonist → decreases gastric acid secretion by parietal cells. |
| Available Forms & Strengths | • Tablet: 20 mg, 40 mg • Oral suspension: 40 mg/5 mL • IV injection: 20 mg/mL |
| Dosage | Adults: 20–40 mg once or twice daily Children: 0.5–1 mg/kg/day divided doses (max 40 mg/day) |
| Route | Oral, IV |
| Common Side Effects |
|
| Serious Adverse Effects | Arrhythmias (rare), hepatotoxicity (rare), confusion (especially elderly) |
| Contraindications | Hypersensitivity to famotidine or other H₂ receptor antagonists |
| Precautions | • Renal impairment (dose adjustment required) • Elderly patients • Pregnancy & lactation: use if benefit outweighs risk |
| Drug Interactions | • Drugs requiring gastric pH-dependent absorption (e.g., ketoconazole, atazanavir) • Cimetidine (rare additive effects) |
| Pregnancy & Lactation | Pregnancy: Generally considered safe Lactation: Use with caution |
| Storage | Store below 30°C, protect from moisture |
| References | BNF | BNF for Children | Goodman & Gilman |